Mizuho initiated coverage of Embecta (EMBC) with a Neutral rating and $15 price target The firm says its rating balances the company’s ...

The global disposable insulin-delivery device market is projected to experience robust growth over the next decade, according to recent industry insights. Valued at USD 14,585.6 million in 2022, the ...

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...

Embecta (Nasdaq:EMBC) announced a new publication introducing best practices for insulin injection techniques and education.

First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") ...

Oklahoma House lawmakers want to lower Insulin's cost for uninsured Oklahomans with diabetes. One bill that passed the chamber this week partners the state with federally funded nonprofits to ...

Segregation and Focus The report meticulously segments the market into various categories, such as personal and professional blood glucose meters, test strips, lancets, insulin pens, syringes ...

Medicare Part D may cover insulin and certain medical supplies for injecting insulin, such as syringes. It may also cover disposable pumps and some oral diabetes medications. A person will need to ...

Long-acting insulin helps people with diabetes maintain normal blood sugar levels throughout the day. Unlike short-acting insulin, it never peaks, keeping an even sugar level in your blood.

Just like Taylor Swift during her Eras Tour, it seems like weight loss supplements are everywhere right now—and that includes insulin resistance supps. So, are insulin resistance supplements ...

receiving insufficient syringes, or getting insufficient insulin. Keeka asked if the insulin problem was nationwide because the private sector had readily available insulin pens. He also expressed ...

Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the ...